BAX:NYSE
Baxter International Inc
$20.08
arrow_upward
+2.19%(+0.43) 1D
Jun 23, 3:14:13 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAX...
Open
$19.50
High
$20.12
Low
$19.42
Mkt. cap
10.38B
Avg. vol.
6.97M
Volume
2.53M
Dividend
0.20%
Quarterly dividend
$0.01
Ex-dividend date
May 29, 2026
52-wk high
$31.76
52-wk low
$15.73
EPS
-$2.14
Beta
0.64
Shares outstanding
516.47M
No. of employees
38K
Open
$19.50
High
$20.12
Low
$19.42
Mkt. cap
10.38B
Avg. vol.
6.97M
Volume
2.53M
Dividend
0.20%
Quarterly dividend
$0.01
Ex-dividend date
May 29, 2026
52-wk high
$31.76
52-wk low
$15.73
EPS
-$2.14
Beta
0.64
Shares outstanding
516.47M
No. of employees
38K
News stories
From sources across the web
AD HOC NEWS
·
4 hours ago
Baxter International focuses on dialysis and hospital portfolio, shares on NYSE under analyst watch
Stock Titan
·
1 day ago
Baxter sets 2050 net-zero target in renamed sustainability report
DirectorsTalk Interviews
·
1 day ago
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5K
Founded1931
HeadquartersDeerfield, Illinois, United States
SectorMedical device
Websitebaxter.com
AI content may include mistakes. Learn more